Intravitreal aflibercept efficacy in neovascular age-related macular degeneration with suboptimal response to anti-vascular endothelial growth factor-A therapy.
CONCLUSION: Almost half of patients presented no fluid on optical coherence tomography at week 12, and there was a clinically significant improvement in best-corrected visual acuity. At week 40, one in five patients did not show intra or subretinal fluid, central macular thickness decreased and best-corrected visual acuity was stabilized compared to baseline.
PMID: 31088111 [PubMed - as supplied by publisher]
Source: European Journal of Ophthalmology - Category: Opthalmology Authors: Monés J, Biarnés M, Macbeth Study Group Tags: Eur J Ophthalmol Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Avastin | Eyes | Lucentis | Opthalmology | Ranibizumab Injection | Study